Clin2
NCT06015802Likely a fitRecruiting

Predicting pituitary tumor behavior with markers and scans

Pituitary AdenomaNeuroendocrine Tumors

Part of Brain & nervous system, Cancer, Hormones & metabolism clinical trials.

This study looks at whether blood and tissue markers, along with imaging features, can predict how aggressive a pituitary neuroendocrine tumor is and how it may affect long-term health. It aims to improve treatment decisions by better understanding these tumors.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 70 years
Study type
Observational

Who can take part

  • You have a pituitary neuroendocrine tumor (previously called a pituitary adenoma).
  • Your diagnosis is based on imaging and, if needed, hormone level tests.
  • You have not had radiation, chemotherapy, immunotherapy, or targeted therapy before.
  • You do not have known genetic syndromes that cause hormone excess, like Carney or MEN1.
  • You do not have another neuroendocrine tumor elsewhere in the body.
  • You are at least one month past any major surgery or three months past pituitary surgery.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06607198Not yet recruiting
Study of pituitary gland tumors using tissue samples

This study looks at pituitary gland tumors (called Pit-NETs) using stored tumor samples and long-term follow-up information. It aims to learn more about how these tumors behave, which might help doctors treat them better in the future.

Rome, Lazio
NCT05237934Recruiting
Study collects tissue samples and tracks neuroendocrine tumors

This study looks at neuroendocrine tumors by collecting tissue (when available) and tracking how the disease behaves over time. It may help researchers better understand these cancers, including rare cases of adrenocortical cancer.

Bethesda, Maryland
NCT07456878Recruiting· Phase 1
New PET/MRI scan for hard-to-find pituitary tumors

This study tests a new type of PET/MRI scan that uses a special tracer (18F-FET) to better find small pituitary tumors that didn't show up on a standard MRI. The goal is to help guide surgery to remove the tumor.

Jacksonville, Florida
NCT04464122Recruiting
Testing blood markers to diagnose and gauge early response in NEN

This trial studies whether specific blood “biomarkers” can help confirm a type of cancer called NEN (neuroendocrine neoplasm) and show whether treatment is working early. It may help doctors start or adjust treatment sooner, especially for cancers that are advanced or have spread.

Rome, Italy
NCT07618949Not yet recruiting
Standardized patient education for pituitary surgery

This study tests whether giving structured education to patients before pituitary surgery helps them prepare better. It aims to improve understanding and recovery by providing clear, standardized information.

NCT07594262Recruiting
Understanding Inflammation in Pituitary Tumors

This research study examines the inflammatory environment inside pituitary tumors (small glands in the brain) to better understand how they grow and respond to treatment. You would have surgery to remove the tumor as part of your normal care, and researchers would study the removed tissue to learn more.

Rome, Lazio

Hear when a new Pituitary Adenoma trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.